| Nathan Thomas Hill, | |
|
5800 W 10th St Ste 610, Little Rock, AR 72204-1761 | |
| (501) 661-9393 | |
| Not Available |
| Full Name | Nathan Thomas Hill |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 10 Years |
| Location | 5800 W 10th St Ste 610, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801207857 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | E-13011 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Baptist Health Medical Center- Conway | Conway, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arkansas Health Group | 7911802079 | 541 |
News Archive
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.
The Centre for Cooperative Research in Biomaterials, CIC biomaGUNE, is involved in the research consortium of cvREMOD, which aims to move forward in the attainment of new diagnosis techniques for prevention and customised treatment of cardiovascular diseases in the upcoming four years.
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Recently, researchers have discovered that the hormone progesterone, an ingredient in contraceptives and menopausal hormone replacement therapies, might stimulate the growth of breast cancer cells that are resistant to anti-estrogen therapy and chemotherapy.
› Verified 6 days ago
| Entity Name | Pulmonary Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215947825 PECOS PAC ID: 9638175409 Enrollment ID: O20061018000612 |
News Archive
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.
The Centre for Cooperative Research in Biomaterials, CIC biomaGUNE, is involved in the research consortium of cvREMOD, which aims to move forward in the attainment of new diagnosis techniques for prevention and customised treatment of cardiovascular diseases in the upcoming four years.
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Recently, researchers have discovered that the hormone progesterone, an ingredient in contraceptives and menopausal hormone replacement therapies, might stimulate the growth of breast cancer cells that are resistant to anti-estrogen therapy and chemotherapy.
› Verified 6 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598031882 PECOS PAC ID: 7911802079 Enrollment ID: O20120611000172 |
News Archive
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.
The Centre for Cooperative Research in Biomaterials, CIC biomaGUNE, is involved in the research consortium of cvREMOD, which aims to move forward in the attainment of new diagnosis techniques for prevention and customised treatment of cardiovascular diseases in the upcoming four years.
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Recently, researchers have discovered that the hormone progesterone, an ingredient in contraceptives and menopausal hormone replacement therapies, might stimulate the growth of breast cancer cells that are resistant to anti-estrogen therapy and chemotherapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Thomas Hill, 5800 W 10th St Ste 610, Little Rock, AR 72204-1761 Ph: (501) 661-9393 | Nathan Thomas Hill, 5800 W 10th St Ste 610, Little Rock, AR 72204-1761 Ph: (501) 661-9393 |
News Archive
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ACE2 receptor. This could indicate its potential for development as a vaccine or antiviral.
A cross-disciplinary Small Medicine and Advanced Research Translation (SMART) team led by Prof. Dar-Bin Shieh of Institute of Oral Medicine in Medical College at National Cheng Kung University (NCKU), Tainan, Taiwan, has announced a breakthrough in the precision in-cell gene scission at pre-designed sequence sites using Artificial Targeting Light Activated Nano Scissors (ATLANS) and a custom build photonic device.
The Centre for Cooperative Research in Biomaterials, CIC biomaGUNE, is involved in the research consortium of cvREMOD, which aims to move forward in the attainment of new diagnosis techniques for prevention and customised treatment of cardiovascular diseases in the upcoming four years.
RaySearch Laboratories AB announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian's Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimization, and conformal optimization.
Recently, researchers have discovered that the hormone progesterone, an ingredient in contraceptives and menopausal hormone replacement therapies, might stimulate the growth of breast cancer cells that are resistant to anti-estrogen therapy and chemotherapy.
› Verified 6 days ago
Lonnie E Harrison, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7 Shackleford West Blvd, Little Rock, AR 72211 Phone: 501-664-5860 Fax: 501-664-0889 | |
Muthu Veera Kumaran, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 556, Little Rock, AR 72205 Phone: 501-686-6033 Fax: 501-686-8932 | |
Armaghan Yunis Soomro, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7282 Fax: 201-277-9765 | |
Tanvi Harishbhai Patel, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 508, Little Rock, AR 72205 Phone: 501-686-7105 Fax: 501-526-5906 | |
Gaurav Dhar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Anthony R Giglia Iii, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5800 W 10th St, Ste 610 Freeway Medical Center, Little Rock, AR 72204 Phone: 501-661-9393 Fax: 501-663-4795 | |
Brian Bean, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: #2 St Vincent Circle, Little Rock, AR 72205 Phone: 501-552-3592 Fax: 501-552-4129 |